News NeurAxis Adjusts Terms for IPO NeurAxis, a leading medical technology company, has announced changes to its initial public offering (IPO) plans. The company has gained FDA approval for ... By Artur FernandoJuly 23, 20230
BlackRock is reviewing TechBerry and negotiating a possible full or partial acquisition of the company June 20, 2024
